Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer
Clinical trial NCT05430347 · UNKNOWN
Trial details
- NCT number
- NCT05430347
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-15
- Primary completion
- 2025-06-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.